T-cadherin is present on endothelial microparticles and is elevated in plasma in early atherosclerosis

European Heart Journal

Volumn 32, Issue 6, 2011, Pages 760-771

  Philippova, Maria ^a   Suter, Yves ^b   Toggweiler, Stefan ^b   Schoenenberger, Andreas W ^c   Joshi, Manjunath B ^a   Kyriakakis, Emmanouil ^a   Erne, Paul ^b   Resink, Thérèse J ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b LUZERNER KANTONSSPITAL   (Switzerland)

^c UNIVERSITY OF BERN   (Switzerland)

Author keywords

Atherosclerosis; Endothelial dysfunction; Endothelial microparticles; Plasma biomarkers; T cadherin

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CADHERIN; CALCIUM ANTAGONIST; CD31 ANTIGEN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LIPOCORTIN 5; PROTEIN KINASE B; T CADHERIN; UNCLASSIFIED DRUG; VASCULAR ENDOTHELIAL CADHERIN;

ADULT; APOPTOSIS; ARTICLE; ATHEROSCLEROSIS; CELL ACTIVATION; CELL PROLIFERATION; CELL STRESS; CHRONIC DISEASE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; ENDOTHELIAL DYSFUNCTION; ENDOTHELIAL MICROPARTICLE; ENDOTHELIUM CELL; ENZYME PHOSPHORYLATION; FEMALE; HUMAN; HUMAN CELL; HYPEREMIA; HYPERLIPIDEMIA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; PROTEIN SECRETION; SIGNAL TRANSDUCTION; TARGET CELL; VASCULAR ENDOTHELIUM;

AGED; ANALYSIS OF VARIANCE; CADHERINS; CELL-DERIVED MICROPARTICLES; CELLS, CULTURED; CORONARY ARTERY DISEASE; EARLY DIAGNOSIS; ENDOTHELIUM, VASCULAR; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; MALE; MIDDLE AGED; SIGNAL TRANSDUCTION; UMBILICAL VEINS;

EID: 79952856179     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehq206     Document Type: Article

References (36)

1. Bonetti PO, Barsness GW, Keelan PC, Schnell TI, Pumper GM, Kuvin JT, Schnall RP, Holmes DR, Higano ST, Lerman A. Enhanced external counterpulsation improves endothelial function in patients with symptomatic coronary artery disease. J Am Coll Cardiol 2003;41:1761-1768. (Pubitemid 36584250)
2. Bonetti PO, Pumper GM, Higano ST, Holmes DR Jr, Kuvin JT, Lerman A. Noninvasive identification of patients with early coronary atherosclerosis by assessment of digital reactive hyperemia. J Am Coll Cardiol 2004;44:2137-2141. (Pubitemid 39576032)
3. Deanfield JE, Halcox JP, Rabelink TJ. Endothelial function and dysfunction: testing and clinical relevance. Circulation 2007;115:1285-1295. (Pubitemid 46594773)
4. Nakou ES, Liberopoulos EN, Milionis HJ, Elisaf MS. The role of C-reactive protein in atherosclerotic cardiovascular disease: an overview. Curr Vasc Pharmacol 2008;6: 258-270.
5. Constans J, Conri C. Circulating markers of endothelial function in cardiovascular disease. Clin Chim Acta 2006;368:33-47. (Pubitemid 43792418)
6. Boulanger CM, Amabile N, Tedgui A. Circulating microparticles: a potential prognostic marker for atherosclerotic vascular disease. Hypertension 2006;48:180-186. (Pubitemid 44309805)
7. Chironi GN, Boulanger CM, Simon A, Dignat-George F, Freyssinet JM, Tedgui A. Endothelial microparticles in diseases. Cell Tissue Res 2009;335:143-151.
8. Hugel B, Martinez MC, Kunzelmann C, Freyssinet JM. Membrane microparticles: two sides of the coin. Physiology (Bethesda) 2005;20:22-27. (Pubitemid 40363367)
9. Philippova M, Joshi MB, Kyriakakis E, Pfaff D, Erne P, Resink TJ. A guide and guard: the many faces of T-cadherin. Cell Signal 2009;21:1035-1044.
10. Resink TJ, Philippova M, Joshi MB, Kyriakakis E, Erne P. Cadherins and cardiovascular disease. Swiss Med Wkly 2009;139:122-134.
11. Ivanov D, Philippova M, Antropova J, Gubaeva F, Iljinskaya O, Tararak E, Bochkov V, Erne P, Resink T, Tkachuk V. Expression of cell adhesion molecule Tcadherin in the human vasculature. Histochem Cell Biol 2001;115:231-242. (Pubitemid 32247200)
12. Kudrjashova E, Bashtrikov P, Bochkov V, Parfyonova Y, Tkachuk V, Antropova J, Iljinskaya O, Tararak E, Erne P, Ivanov D, Philippova M, Resink TJ. Expression of adhesion molecule T-cadherin is increased during neointima formation in experimental restenosis. Histochem Cell Biol 2002;118:281-290. (Pubitemid 35216471)
13. Ivanov D, Philippova M, Allenspach R, Erne P, Resink T. T-cadherin upregulation correlates with cell-cycle progression and promotes proliferation of vascular cells. Cardiovasc Res 2004;64:132-143. (Pubitemid 39208930)
14. Joshi MB, Philippova M, Ivanov D, Allenspach R, Erne P, Resink TJ. T-cadherin protects endothelial cells from oxidative stress-induced apoptosis. FASEB J 2005;19: 1737-1739. (Pubitemid 41429547)
15. Kyriakakis E, Joshi MB, Philipova M, Erne P, Resink TJ. Endoplasmic reticulum stress and the role of T-cadherin. FEBS J 2008;275(Suppl. 1):411.
16. Philippova M, Banfi A, Ivanov D, Gianni-Barrera R, Allenspach R, Erne P, Resink T. Atypical GPI-anchored T-cadherin stimulates angiogenesis in vitro and in vivo. Arterioscler Thromb Vasc Biol 2006;26:2222-2230. (Pubitemid 44465715)
17. Suter Y, Schoenenberger AW, Toggweiler S, Jamshidi P, Resink T, Erne P. Intravascular ultrasound-based left main coronary artery assessment: comparison between pullback from left anterior descending and circumflex arteries. J Inv Cardiol 2009;21:457-460.
18. Ivanov D, Philippova M, Tkachuk V, Erne P, Resink T. Cell adhesion molecule Tcadherin regulates vascular cell adhesion, phenotype and motility. Exp Cell Res 2004;293:207-218. (Pubitemid 38083210)
19. Philippova M, Ivanov D, Tkachuk V, Erne P, Resink TJ. Polarisation of T-cadherin to the leading edge of migrating vascular cells in vitro: a function in vascular cell motility? Histochem Cell Biol 2003;120:353-360. (Pubitemid 38005354)
20. Martinez MC, Tesse A, Zobairi F, Andriantsitohaina R. Shed membrane microparticles from circulating and vascular cells in regulating vascular function. Am J Physiol Heart Circ Physiol 2005;288:H1004-H1009. (Pubitemid 40269999)
21. Arribas J, Borroto A. Protein ectodomain shedding. Chem Rev 2002;102: 4627-4638.
22. Lauc G, Heffer-Lauc M. Shedding and uptake of gangliosides and glycosylphosphatidylinositol-anchored proteins. Biochim Biophys Acta 2006;1760: 584-602.
23. Blankenberg S, Barbaux S, Tiret L. Adhesion molecules and atherosclerosis. Atherosclerosis 2003;170:191-203. (Pubitemid 37377790)
24. Horstman LL, Jy W, Jimenez JJ, Ahn YS. Endothelial microparticles as markers of endothelial dysfunction. Front Biosci 2004;9:1118-1135. (Pubitemid 39060833)
25. Thery C, Zitvogel L, Amigorena S. Exosomes: composition, biogenesis and function. Nat Rev Immunol 2002;2:569-579. (Pubitemid 37328732)
26. Chatzizisis YS, Coskun AU, Jonas M, Edelman ER, Feldman CL, Stone PH. Role of endothelial shear stress in the natural history of coronary atherosclerosis and vascular remodeling: molecular, cellular, and vascular behavior. J Am Coll Cardiol 2007; 49:2379-2393. (Pubitemid 46962266)
27. Lynch SF, Ludlam CA. Plasma microparticles and vascular disorders. Br J Haematol 2007;137:36-48. (Pubitemid 46426401)
28. Tuzcu EM, Kapadia SR, Tutar E, Ziada KM, Hobbs RE, McCarthy PM, Young JB, Nissen SE. High prevalence of coronary atherosclerosis in asymptomatic teenagers and young adults: evidence from intravascular ultrasound. Circulation 2001; 103:2705-2710. (Pubitemid 32538786)
29. Packard RR, Libby P. Inflammation in atherosclerosis: from vascular biology to biomarker discovery and risk prediction. Clin Chem 2008;54:24-38. (Pubitemid 351182593)
30. Kyriakakis E, Philippova M, Joshi MB, Pfaff D, Bochkov V, Afonyushkin T, Erne P, Resink TJ. T-cadherin attenuates the PERK branch of the unfolded protein response and protects vascular endothelial cells from endoplasmic reticulum stress-induced apoptosis. Cell Signall 2010; doi:10.1016/j.cellsig 2010.04
31. Nozaki T, Sugiyama S, Koga H, Sugamura K, Ohba K, Matsuzawa Y, Sumida H, Matsui K, Jinnouchi H, Ogawa H. Significance of a multiple biomarkers strategy including endothelial dysfunction to improve risk stratification for cardiovascular events in patients at high risk for coronary heart disease. J Am Coll Cardiol 2009;54: 601-608.
32. Bernard S, Loffroy R, Serusclat A, Boussel L, Bonnefoy E, Thevenon C, Rabilloud M, Revel D, Moulin P, Douek P. Increased levels of endothelial microparticles CD144 (VE-Cadherin) positives in type 2 diabetic patients with coronary noncalcified plaques evaluated by multidetector computed tomography (MDCT). Atherosclerosis 2009;203:429-435.
33. Levy D, Larson MG, Benjamin EJ, Newton-Cheh C, Wang TJ, Hwang SJ, Vasan RS, Mitchell GF. Framingham Heart Study 100K Project: genome-wide associations for blood pressure and arterial stiffness. BMC Med Genet 2007; 8(Suppl. 1):S3.
34. Org E, Eyheramendy S, Juhanson P, Gieger C, Lichtner P, Klopp N, Veldre G, Doring A, Viigimaa M, Sober S, Tomberg K, Eckstein G, Kelgo P, Rebane T, Shaw-Hawkins S, Howard P, Onipinla A, Dobson RJ, Newhouse SJ, Brown M, Dominiczak A, Connell J, Samani N, Farrall M, Caulfield MJ, Munroe PB, Illig T, Wichmann HE, Meitinger T, Laan M. Genome-wide scan identifies CDH13 as a novel susceptibility locus contributing to blood pressure determination in two European populations. Hum Mol Genet 2009;18:2288-2296.
35. Hug C, Wang J, Ahmad NS, Bogan JS, Tsao TS, Lodish HF. T-cadherin is a receptor for hexameric and high-molecular-weight forms of Acrp30/adiponectin. Proc Natl Acad Sci USA 2004;101:10308-10313. (Pubitemid 38924921)
36. Kipmen-Korgun D, Osibow K, Zoratti C, Schraml E, Greilberger J, Kostner GM, Jurgens G, Graier WF. T-cadherin mediates low-density lipoprotein-initiated cell proliferation via the Ca(2+)-tyrosine kinase-Erk1/2 pathway. J Cardiovasc Pharmacol 2005;45:418-430. (Pubitemid 40637202)